ELVN ▲ +0.1% - Enliven Therapeutics, Inc. $ELVN ELVN ELVN - Enliven Therapeutics Announces Oral and Poster Presentations at the Society of Hematologic Oncology (SOHO) 2026 Annual Meeting Enliven Therapeutics rose 0.1% following the announcement that the company will present oral and poster presentations at the Society of Hematologic Oncology's 2026 Annual Meeting, offering investors visibility into upcoming clinical data or research updates in hematologic oncology. 31-AUG-2026 06:06 PM ET